bpc-157 ulcerative colitis bpc 157 for Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights Stable gastric pentadecapeptide BPC 157

This depends on dose and vial size: 2mg vial at 200mcg/dose = 10 doses 2mg vial at 300mcg/dose = 6.6 doses (approximately 6) 5mg vial at 200mcg/dose = 25 doses 5mg vial at 300mcg/dose = 16.6 doses (approximately 16) At a standard protocol of 200-300mcg once or twice daily, a 5mg vial lasts 8-25 days depending on frequency and dose

10.1515/revneuro-2014-0041 [DOI] [PubMed] [Google Scholar] Lojo, N

The strongest published finding is from the foundational Biochemical Pharmacology study by Neelakantan et al.: in diet-induced obese mice, daily 5-Amino-1MQ administration produced reductions in body weight, white adipose tissue mass, and adipocyte size without any significant change in food intake

Its still an experimental synthetic peptide with limited human study results